宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月3日公告回购25,400股股份，占当日公司已发行股本约0.0061%。每股回购价格介乎3.80港元至3.93港元，合计支付约9.82万港元。
本次回购完成后，公司已发行股本变动为419,010,105股，库存股份增至1,467,200股。公司于2026年5月28日通过购回授权，可购回股份总数为43,150,769股，目前已回购1,467,200股。
公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.